A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00386867 |
Recruitment Status
:
Completed
First Posted
: October 12, 2006
Last Update Posted
: June 5, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Abortion, Induced | Drug: 800 mcg misoprostol via oral or buccal administration | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1200 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Study Start Date : | October 2006 |
Study Completion Date : | March 2007 |

- efficacy
- acceptability

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- be willing and able to sign consent forms;
- be eligible for medical abortion according to clinician’s assessment;
- be willing to undergo a surgical completion if necessary;
- have ready and easy access to a telephone and emergency transportation;
- speak English, Spanish, or have a translator available to translate for all study procedures; and,
- agree to comply with the study procedures and visit schedule.
Exclusion Criteria:
- Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass;
- IUD in place;
- Chronic renal failure;
- Concurrent long-term corticosteroid therapy;
- History of allergy to mifepristone, misoprostol or other prostaglandin;
- Hemorrhagic disorders or concurrent anticoagulant therapy;
- Inherited porphyrias; or
- Other serious physical or mental health conditions.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00386867
United States, Illinois | |
Family Planning Associates Medical Group | |
Chicago, Illinois, United States | |
United States, Massachusetts | |
Planned Parenthood League of Massachusetts (Boston clinic) | |
Boston, Massachusetts, United States | |
United States, New York | |
Columbia University Medical Center, Division of Obstetrics & Gynecology | |
New York, New York, United States | |
Institute for Urban Family Health | |
New York, New York, United States | |
Parkmed | |
New York, New York, United States | |
United States, Pennsylvania | |
University of Pittsburgh, Division of Obstetrics, Gynecology and Reproductive Sciences | |
Pittsburgh, Pennsylvania, United States | |
United States, Texas | |
Whole Women’s Health | |
Austin, Texas, United States | |
Planned Parenthood | |
Waco, Texas, United States |
Principal Investigator: | Beverly Winikoff, MD, MPH | Gynuity Health Projects | |
Study Director: | Ilana Dzuba, MHS | Gynuity Health Projects |
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00386867 History of Changes |
Other Study ID Numbers: |
1.1.3 |
First Posted: | October 12, 2006 Key Record Dates |
Last Update Posted: | June 5, 2007 |
Last Verified: | June 2007 |
Keywords provided by Gynuity Health Projects:
medical abortion mifepristone misoprostol buccal administration |
Additional relevant MeSH terms:
Misoprostol Mifepristone Abortifacient Agents, Nonsteroidal Abortifacient Agents Reproductive Control Agents Physiological Effects of Drugs Anti-Ulcer Agents Gastrointestinal Agents Oxytocics Abortifacient Agents, Steroidal |
Contraceptives, Oral, Synthetic Contraceptives, Oral Contraceptive Agents, Female Contraceptive Agents Contraceptives, Postcoital, Synthetic Contraceptives, Postcoital Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Luteolytic Agents Menstruation-Inducing Agents |